Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytosorbents Cor
(NQ:
CTSO
)
0.9665
+0.0715 (+7.99%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytosorbents Cor
< Previous
1
2
3
4
5
Next >
CTSO Stock Earnings: CytoSorbents Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
August 13, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024
CytoSorbents CFO Kathleen P. Bloch Retires
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
August 07, 2024
From
CytoSorbents
Via
GlobeNewswire
Recap: CytoSorbents Q4 Earnings
March 14, 2024
Via
Benzinga
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
August 01, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 29, 2024
“Working to Save Lives Together” Theme Highlights Two Decades of Successful Collaboration with the International Medical and Research Communities to Help Patients Survive Life-Threatening Illnesses
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
July 17, 2024
From
CytoSorbents
Via
GlobeNewswire
A Preview Of CytoSorbents's Earnings
March 13, 2024
Via
Benzinga
Why CytoSorbents (CTSO) Stock Is Trading Higher
July 02, 2024
CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group.
Via
Benzinga
CytoSorbents Secures $20 Million Credit Facility
July 02, 2024
Credit facility provides timely non-dilutive capital to support ongoing global commercialization of CytoSorb® as well as regulatory submissions and potential commercialization plans for DrugSorb™-ATR...
From
CytoSorbents
Via
GlobeNewswire
What To Know About HC Wainwright & Co.'s Downgrade of CytoSorbents
December 29, 2023
Via
Benzinga
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
June 24, 2024
Brings a powerful blood purification technology used to treat critically ill and cardiac surgery patients in nearly a quarter million treatments across 75 countries to date to one of the most...
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
June 13, 2024
By enabling more rapid and easy treatment, PuriFi is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification cartridge for critically ill patients in the...
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
June 05, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
June 04, 2024
From
CytoSorbents
Via
GlobeNewswire
CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024
May 09, 2024
CTSO stock results show that CytoSorbents met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
CytoSorbents Reports First Quarter 2024 Results
May 09, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
May 02, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
April 26, 2024
From
CytoSorbents
Via
GlobeNewswire
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
April 17, 2024
From
CytoSorbents
Via
GlobeNewswire
CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023
March 14, 2024
CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
From
CytoSorbents
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
March 06, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
February 08, 2024
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
January 17, 2024
CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and Dysfunction
From
CytoSorbents
Via
GlobeNewswire
CYTOSORBENTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm
January 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Gold Moves Lower; US Crude Stocks Decline Last Week
December 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.